High-value AI use cases in pharma
Potential use cases include document drafting, controlled knowledge retrieval, deviation triage support, trend identification, training support, validation traceability and comparison of requirements with test coverage. Some organizations also explore predictive maintenance, process monitoring and laboratory-data analysis.
The regulatory and patient risk varies significantly by use case. A drafting assistant is not governed in the same way as an algorithm influencing a manufacturing control or product-quality decision.
Classify by intended use and risk
Define the business process, users, inputs, outputs, decisions influenced and potential impact on patient safety, product quality and data integrity. This enables proportionate supplier assessment, testing, oversight and change control.
Avoid classifying technology only by the label AI. Governance should address what the function actually does and how the organization relies on its output.
Keep people accountable
Human oversight must be meaningful. Reviewers need access to source evidence, enough time and competence to challenge output, and authority to reject it. Procedures should prevent automation bias and define escalation when output is incomplete, inconsistent or unsupported.
Performance monitoring and periodic review help confirm that the use case continues to operate within its approved boundaries.
Start with controlled validation workflows
Validation documentation is a practical starting point because the inputs, lifecycle steps, reviews and approvals can be clearly defined. PHARPRO DVS embeds AI-assisted drafting within connected validation records rather than separating AI output from the controlled process.
Teams can pilot measurable use cases while retaining traceability and formal human approval.
Frequently asked questions
What is the safest way to start using AI in pharma?
Begin with a bounded, lower-risk use case, define governance and success criteria, pilot it with trained users and measure output quality before scaling.
Can confidential GxP data be entered into any AI tool?
No. Data classification, supplier terms, security, privacy, retention and approved-use procedures must be assessed before entering regulated or confidential information.
How does PHARPRO DVS use AI?
DVS uses AI-assisted drafting within validation-specific workflows while qualified users review, correct and approve the resulting records.
See PHARPRO DVS in action
Explore connected validation documents, requirements traceability, controlled review and AI-assisted drafting with qualified human approval.
Explore PHARPRO DVS & book a demo →